Why is Fortis Healthcare Ltd falling/rising?

Recent Price Performance and Market Context

Fortis Healthcare’s recent price action demonstrates resilience and strength relative to broader market indices. Over the past week, the stock has gained 1.74%, outperforming the Sensex’s 0.95% rise. More impressively, the one-month return stands at 9.33%, contrasting sharply with the Sensex’s decline of 4.08% during the same period. Year-to-date, Fortis has delivered a positive return of 10.24%, while the Sensex has fallen by 11.62%. This divergence highlights the stock’s ability to buck broader market weakness and attract investor interest.

Today’s price increase also marks a reversal after three consecutive days of decline, signalling renewed buying momentum. The stock’s current trading level is above all key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day averages — which is a technical indicator of sustained upward momentum and investor confidence.

Fundamental Strength Supporting the Rise

Fortis Healthcare’s rise is underpinned by strong fundamental metrics that appeal to both retail and institutional investors. The company maintains a low Debt to EBITDA ratio of 1.72 times, indicating a healthy capacity to service its debt obligations without undue financial strain. This prudent leverage position reduces risk and enhances investor confidence in the company’s financial stability.

Moreover, the company has demonstrated exceptional long-term growth, with operating profit expanding at an annualised rate of 115.19%. Such robust profitability growth is a key driver behind the stock’s impressive returns and market outperformance. Over the last year, Fortis Healthcare has generated a remarkable 43.30% return, significantly outperforming the Sensex’s negative 7.23% return. Extending the horizon, the stock has delivered a staggering 245.76% return over three years and an extraordinary 339.83% over five years, far surpassing the Sensex’s respective gains of 22.01% and 51.96%.

Institutional investors hold a substantial 57.17% stake in Fortis Healthcare, reflecting strong confidence from entities with extensive resources and analytical capabilities. This high level of institutional ownership often provides a stabilising influence on the stock and suggests that the company’s fundamentals have been thoroughly vetted by sophisticated market participants.

Trading Activity and Liquidity Considerations

Despite the positive price movement, investor participation has slightly waned, with delivery volumes on 19 May falling by 10.37% compared to the five-day average. However, the stock remains sufficiently liquid, with the capacity to handle trade sizes of approximately ₹2.2 crores based on 2% of the five-day average traded value. This liquidity ensures that investors can enter or exit positions without significant price disruption, supporting continued market interest.

Conclusion: Why Fortis Healthcare Is Rising

The rise in Fortis Healthcare’s stock price on 20-May is a reflection of its strong fundamental position, consistent long-term growth, and ability to outperform broader market indices. The company’s low leverage, impressive operating profit growth, and high institutional ownership provide a solid foundation for investor confidence. Additionally, the technical indicators, including the stock trading above all major moving averages and a reversal after a short-term decline, signal positive momentum.

While delivery volumes have dipped slightly, liquidity remains adequate, ensuring smooth trading conditions. Overall, Fortis Healthcare’s recent price appreciation is supported by a combination of robust financial health, market outperformance, and renewed buying interest, making it a stock that continues to attract attention in the healthcare sector.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →